Memorandum from NZSG

Posted Thursday April 6, 2023

The NZSG Working Group for IBD Medication after discussion with NZSG members, Pharmac and pharmaceutical company representatives have written an e-guidance document on ustenkinumab treatment and ongoing maintenance doses. Please find this on the NZSG website

Gallery

Related Articles

Pharmac Decision to fully fund oral nutrition replacements

Monday July 21, 2025

Pharmac is fully funding two liquid nutrition replacements for adults with Crohn’s disease effective from 1 July 2025.

Pharma News

Read more »

Informative Articles in Digestive Diseases and Sciences – Vol. 70, Issue 5 (May 2025)

Monday June 9, 2025

Digestive Diseases and Sciences released its May 2025 issue—Volume 70, Issue 5 It includes a Special Issue titled “Evalu...

News

Read more »

NZSG is on LinkedIn

Monday June 9, 2025

We're proud to announce we've joined the LinkedIn network follow us!

News

Read more »